Enkorten – A Potential Drug for the Treatment of Rheumatoid Arthritis
| Autor: | Svjetlana Loga-Zec, Aida Kulo, Mirjana Mijanović, Lejla Burnazović-Ristić, Asija Zaciragic, Maida Todić-Rakanović, Jasna Kusturica, Fahir Becić, Selma Škrbo, Nedzad Mulabegović |
|---|---|
| Rok vydání: | 2012 |
| Předmět: |
chemistry.chemical_classification
Drug endocrine system animal structures integumentary system biology media_common.quotation_subject Neuropeptide Endogeny Peptide Pharmacology medicine.disease Amino acid chemistry Proopiomelanocortin Rheumatoid arthritis medicine biology.protein hormones hormone substitutes and hormone antagonists media_common |
| Zdroj: | Rheumatoid Arthritis-Treatment |
| DOI: | 10.5772/25706 |
| Popis: | Enkorten is a new potential drug for the treatment of rheumatoid arthritis, with an immunomodulatory and anti-inflammatory effect. It is a combination of two peptide components of endogenous origin: methionine-enkephalin of 5 mg and tridecactide of 1 mg (Picture 1 and 2). According to the chemical structures, these components correspond to amino acid sequences of the neuropeptide precursor proopiomelanocortin. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|